ArticleReviews in cardiovascular medicine2023

The Effectiveness and Safety of Intensive Lipid-Lowering with Different Rosuvastatin-Based Regimens in Patients at High Cardiovascular Disease Risk: A Nonblind, Randomized, Controlled Trial.

Lili Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.